Cargando…

Androgen Deprivation Therapy and Cardiovascular Risk in Chinese Patients with Nonmetastatic Carcinoma of Prostate

Background. Androgen deprivation therapy (ADT) in nonmetastatic prostate cancer is unclear. Recent data suggests possible increase in the cardiovascular risks receiving ADT. The aim of the study was to investigate the cardiovascular outcomes in a cohort of Chinese nonmetastatic prostate cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Gang, Yeung, Chun-Yip, Lee, Ka Kui, Liu, Jianxiong, Ho, Kwan Lun, Yiu, Ming-Kwong, Lam, Karen Siu-Ling, Tse, Hung-Fat, Yau, Thomas, Siu, Chung-Wah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997904/ https://www.ncbi.nlm.nih.gov/pubmed/24803931 http://dx.doi.org/10.1155/2014/529468

Ejemplares similares

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma
por: Lee, Chi-Ho, et al.
Publicado: (2017)

Sudden Cardiac Death After Myocardial Infarction in Type 2 Diabetic Patients With No Residual Myocardial Ischemia
por: Yeung, Chun-Yip, et al.
Publicado: (2012)

Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE
por: Gong, Jun, et al.
Publicado: (2022)

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
por: Hussain, Arif, et al.
Publicado: (2020)

Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers
por: Fang, Dong, et al.
Publicado: (2019)

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
por: Shida, Yohei, et al.
Publicado: (2017)

Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
por: D'Amico, Anthony V., et al.
Publicado: (2021)

Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancer
por: Forster, Rachel B., et al.
Publicado: (2022)

Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention
por: Hang Yiu, Kai, et al.
Publicado: (2011)

Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials
por: Ma, Ting Martin, et al.
Publicado: (2023)

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus
por: Yue, Wen-Sheng, et al.
Publicado: (2011)

Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2011)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic
por: Tam, Chor-Cheung Frankie, et al.
Publicado: (2021)

Overexpression of myocardin induces partial transdifferentiation of human‐induced pluripotent stem cell‐derived mesenchymal stem cells into cardiomyocytes
por: Zhang, Jiao, et al.
Publicado: (2014)

PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights
por: Chan, Yap-Hang, et al.
Publicado: (2017)

Isogenic Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes Reveal Activation of Wnt Signaling Pathways Underlying Intrinsic Cardiac Abnormalities in Rett Syndrome
por: Ng, Kwong-Man, et al.
Publicado: (2022)

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
por: Saad, Fred, et al.
Publicado: (2021)

Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress
por: Zhao, Chun Ting, et al.
Publicado: (2012)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus
por: Yiu, Kai-Hang, et al.
Publicado: (2013)

Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin
por: Hai, Jo-Jo, et al.
Publicado: (2019)

Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies
por: Zhang, Jennifer, et al.
Publicado: (2021)

Editorial to “Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation”
por: Lau, Chu‐Pak, et al.
Publicado: (2020)

State-Dependent Accessibility of the P-S6 Linker of Pacemaker (HCN) Channels Supports a Dynamic Pore-to-Gate Coupling Model
por: Siu, Chung Wah, et al.
Publicado: (2009)

Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons
por: Law, Cheuk-Yiu, et al.
Publicado: (2016)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2014)

Attenuation of Hind-Limb Ischemia in Mice with Endothelial-Like Cells Derived from Different Sources of Human Stem Cells
por: Lai, Wing-Hon, et al.
Publicado: (2013)

Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer
por: Kinaan, Mustafa, et al.
Publicado: (2020)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Androgen deprivation in prostate cancer: benefits of home-based resistance training
por: Lam, Teresa, et al.
Publicado: (2020)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Reply: Prostate cancer, insulin and androgen deprivation therapy
por: Lehrer, S
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_op9viotokej1c8utpd1svmjfra